tiprankstipranks
Trending News
More News >
Emergent Biosolutions (EBS)
NYSE:EBS
US Market

Emergent Biosolutions (EBS) Income Statement

Compare
1,360 Followers

Emergent Biosolutions Income Statement

Last quarter (Q3 2025), Emergent Biosolutions's total revenue was $231.10M, an increase of 18.70% from the same quarter last year. In Q3, Emergent Biosolutions's net income was $51.20M. See Emergent Biosolutions’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 1.04B$ 1.05B$ 1.12B$ 1.77B$ 1.58B
Gross Profit
$ 375.40M$ 360.00M$ 473.00M$ 793.20M$ 863.10M
Operating Expenses
$ 484.10M$ 1.09B$ 643.00M$ 451.80M$ 424.60M
Depreciation and Amortization
$ 105.60M$ 121.10M$ 125.00M$ 118.20M$ 110.00M
EBITDA
$ 53.40M$ -47.00M$ 15.70M$ 504.20M$ 609.20M
Operating Income
$ -108.70M$ -726.40M$ -170.00M$ 341.40M$ 438.50M
Other Income/Expenses
$ -34.20M$ -4.80M$ -49.00M$ -38.20M$ -26.60M
Pretax Income
$ -142.90M$ -731.20M$ -219.00M$ 303.20M$ 411.90M
Net Income
$ -190.60M$ -760.50M$ -211.60M$ 219.50M$ 305.80M
Per Share Metrics
Basic EPS
$ -3.60$ -14.85$ -4.47$ 4.10$ 5.79
Diluted EPS
$ -3.60$ -14.85$ -4.47$ 4.06$ 5.67
Weighted Average Shares Outstanding
53.00M 51.20M 50.10M 53.50M 52.70M
Weighted Average Shares Outstanding (Diluted)
53.00M 51.20M 50.10M 54.10M 53.80M
Currency in USD

Emergent Biosolutions Earnings and Revenue History